SLP News and Press, Simulations Plus Inc. From 07/14/25

Investment to accelerate innovations in biopharma development through Corporate Development Initiative Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligen...

Updated full-year revenue guidance of between $76 to $80 million and adjusted diluted EPS of $0.93 to $1.06 Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled ...

Equity Bancshares Inc. Class A (EQBK) is expected to report $0.9 for Q2 2025 Fastenal Company (FAST) is expected to report $0.28 for Q2 2025 MDJM LTD (UOKA) is expected to report for quarter end 2025-03-31 Magic Empire Global Limited (MEGL) is expected to report for quarter end 2025-0...

Simulations Plus Inc. (SLP) is expected to report $0.26 for Q3 2025

2025-07-13 18:46:08 ET Simulations Plus, Inc. (SLP) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.47%. The average open to low on the day of earnings was -5.32%. The average open to ...

2025-07-13 17:35:00 ET More on Simulations Plus Simulations Plus: Further Downside Is Likely (Rating Downgrade) Simulations Plus: Benefiting From FDA Modernization And AI Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations ...

2025-07-13 08:00:06 ET The upcoming week marks the beginning of earnings season, with a lineup of heavyweights across banking, healthcare, tech, and industrials.... Read the full article on Seeking Alpha For further details see: Earnings week ahead: JPM, BAC, GS, MS, C,...

2025-07-11 15:00:55 ET More on the markets A Market-Topping Volatility Trade Is Sending A Warning Message, Again Debt Ceiling Increase Will Allow U.S. Treasury To Resume Borrowing If You Were Buying In April, You Should Be Trimming In July Trump slaps 35% lev...

To be released on July 14, 2025, with conference call at 5 p.m. ET Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, a...

2025-06-13 08:45:00 ET Simulations Plus' ( SLP ) share price plummeted after the company reported preliminary Q3 FY25 results that fell well short of expectations. While soft biopharma market conditions and Simulations Plus' relatively large services business mean that curre...